3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole has been researched along with Breast Neoplasms in 7 studies
3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole: antineoplastic; activates platelet guanylate cyclase; a radiosensitizing agent and guanylate cyclase activator; structure in first source
lificiguat : A member of the class of indazoles that is 1H-indazole which is substituted by a benzyl group at position 1 and a 5-(hydroxymethyl)-2-furyl group at position 3. It is an activator of soluble guanylate cyclase and inhibits platelet aggregation.
Breast Neoplasms: Tumors or cancer of the human BREAST.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, J | 1 |
| Zhang, C | 1 |
| Zhao, Y | 1 |
| Yue, X | 1 |
| Wu, H | 1 |
| Huang, S | 1 |
| Chen, J | 1 |
| Tomsky, K | 1 |
| Xie, H | 1 |
| Khella, CA | 1 |
| Gatza, ML | 1 |
| Xia, D | 1 |
| Gao, J | 1 |
| White, E | 1 |
| Haffty, BG | 1 |
| Hu, W | 1 |
| Feng, Z | 1 |
| Lee, JC | 1 |
| Chou, LC | 1 |
| Lien, JC | 1 |
| Wu, JC | 1 |
| Huang, CH | 1 |
| Chung, CH | 1 |
| Lee, FY | 2 |
| Huang, LJ | 2 |
| Kuo, SC | 2 |
| Way, TD | 1 |
| Chang, LC | 1 |
| Lin, HY | 1 |
| Tsai, MT | 1 |
| Chou, RH | 1 |
| Teng, CM | 1 |
| Hsieh, MT | 1 |
| Hung, HY | 1 |
| Yu, YL | 1 |
| Aguilar, H | 1 |
| Urruticoechea, A | 1 |
| Halonen, P | 1 |
| Kiyotani, K | 1 |
| Mushiroda, T | 1 |
| Barril, X | 1 |
| Serra-Musach, J | 1 |
| Islam, A | 1 |
| Caizzi, L | 1 |
| Di Croce, L | 1 |
| Nevedomskaya, E | 1 |
| Zwart, W | 1 |
| Bostner, J | 1 |
| Karlsson, E | 1 |
| Pérez Tenorio, G | 1 |
| Fornander, T | 1 |
| Sgroi, DC | 1 |
| Garcia-Mata, R | 1 |
| Jansen, MP | 1 |
| García, N | 1 |
| Bonifaci, N | 1 |
| Climent, F | 1 |
| Soler, MT | 1 |
| Rodríguez-Vida, A | 1 |
| Gil, M | 1 |
| Brunet, J | 1 |
| Martrat, G | 1 |
| Gómez-Baldó, L | 1 |
| Extremera, AI | 1 |
| Figueras, A | 1 |
| Balart, J | 1 |
| Clarke, R | 1 |
| Burnstein, KL | 1 |
| Carlson, KE | 1 |
| Katzenellenbogen, JA | 1 |
| Vizoso, M | 1 |
| Esteller, M | 1 |
| Villanueva, A | 1 |
| Rodríguez-Peña, AB | 1 |
| Bustelo, XR | 1 |
| Nakamura, Y | 1 |
| Zembutsu, H | 1 |
| Stål, O | 1 |
| Beijersbergen, RL | 1 |
| Pujana, MA | 1 |
| Cheng, Y | 1 |
| Li, W | 1 |
| Liu, Y | 1 |
| Cheng, HC | 1 |
| Ma, J | 1 |
| Qiu, L | 1 |
| Harrison, H | 1 |
| Rogerson, L | 1 |
| Gregson, HJ | 1 |
| Brennan, KR | 1 |
| Clarke, RB | 1 |
| Landberg, G | 1 |
| Hiraga, T | 1 |
| Kizaka-Kondoh, S | 1 |
| Hirota, K | 1 |
| Hiraoka, M | 1 |
| Yoneda, T | 1 |
7 other studies available for 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole and Breast Neoplasms
| Article | Year |
|---|---|
Parkin targets HIF-1α for ubiquitination and degradation to inhibit breast tumor progression.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Down-Regulation; Female; Heterografts; H | 2017 |
CLC604 preferentially inhibits the growth of HER2-overexpressing cancer cells and sensitizes these cells to the inhibitory effect of Taxol in vitro and in vivo.
Topics: Animals; Antibiotics, Antineoplastic; Antibodies, Monoclonal, Humanized; Apoptosis; Breast Neoplasms | 2013 |
YC-1 inhibits proliferation of breast cancer cells by down-regulating EZH2 expression via activation of c-Cbl and ERK.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Proliferation; Cell Survival; Dose-Response R | 2014 |
VAV3 mediates resistance to breast cancer endocrine therapy.
Topics: Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Biomarkers, Tumor; Breast; Br | 2014 |
YC-1 exerts inhibitory effects on MDA-MB-468 breast cancer cells by targeting EGFR in vitro and in vivo under normoxic condition.
Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Prol | 2012 |
Contrasting hypoxic effects on breast cancer stem cell hierarchy is dependent on ER-α status.
Topics: Animals; Blotting, Western; Breast Neoplasms; Cell Hypoxia; Cell Line, Tumor; Estrogen Antagonists; | 2013 |
Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer.
Topics: Animals; Bone Neoplasms; Breast Neoplasms; Caspase 3; Cell Hypoxia; Cell Line, Tumor; Female; Humans | 2007 |